Daniele Napolitano

Dr. Daniele Napolitano

SITRA - CEMAD, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
VCVALENTIN CALVEZ
VALENTIN CALVEZ
PPPierluigi Puca
Pierluigi Puca
FVFederica Di Vincenzo
Federica Di Vincenzo
AGAngelo Del Gaudio
Angelo Del Gaudio
BBBianca Bartocci
Bianca Bartocci
FSFRANCO SCALDAFERRI
FRANCO SCALDAFERRI
Inflammatory bowel diseases (IBDs), encompassing Crohn’s disease and ulcerative colitis, are complex chronic disorders characterized by an intricate interplay between genetic predisposition, immune dysregulation, gut microbiota alterations, and environmental exposures. This review aims to synthesize recent advances in IBD pathogenesis, exploring key mechanisms and potential avenues for prevention and personalized therapy. A comprehensive literature search was conducted across major bibliographic databases, selecting the most recent and impactful studies on IBD pathogenesis. The review integrates findings from multi-omics analyses, single-cell transcriptomics, and longitudinal cohort studies, focusing on immune regulation, gut microbiota dynamics, and environmental factors influencing disease onset and progression. Immune dysregulation, including macrophage polarization (M1 vs. M2) and Th17 activation, emerges as a cornerstone of IBD pathogenesis. Dysbiosis, as a result of reduced alpha and beta diversity and overgrowth of harmful taxa, is one of the main contributing factors in causing inflammation in IBD. Environmental factors, including air and water pollutants, maternal smoking, and antibiotic exposure during pregnancy and infancy, significantly modulate IBD risk through epigenetic and microbiota-mediated mechanisms. While recent advances have supported the development of new therapeutic strategies, deeply understanding the complex dynamics of IBD pathogenesis remains challenging. Future efforts should aim to reduce the burden of disease with precise, personalized treatments and lower the incidence of IBD through early-life prevention and targeted interventions addressing modifiable risk factors.

24 September 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
MPMarco Pizzoferrato
Marco Pizzoferrato
RSRoberto De Sire
Roberto De Sire
FIFabio Ingravalle
Fabio Ingravalle
MMMaria Chiara Mentella
Maria Chiara Mentella
VPValentina Petito
Valentina Petito
Antonio GasbarriniAntonio Gasbarrini
Antonio Gasbarrini
(1) Background: There is growing interest in the assessment of muscular mass in inflammatory bowel disease (IBD) as sarcopenia is associated with important outcomes. The aim of the study was to evaluate the percentage of sarcopenia in IBD patients, characterizing methods for assessment and clinical symptoms associated to it. (2) Methods: Consecutive IBD patients accessing the Fondazione Policlinico Agostino Gemelli Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) were enrolled. Healthy patients, elderly or elderly sarcopenic patients, were enrolled as controls. Skeletal muscle mass was evaluated by Dual Energy X-ray Absorptiometry (DEXA) or Bio-Impedensometric Analysis (BIA). Asthenia degree was assessed by subjective visual analogue scales (VAS). Quality of life was measured by the EQ-5D questionnaire. (3) Results: Patients with IBD showed a significant reduction in skeletal muscle mass than healthy controls with lower DEXA and BIA parameters. Moreover, IBD patients presented a lower perception of muscle strength with a higher incidence of asthenia and reduction in quality of life when compared with healthy controls. A significant association between loss in skeletal muscle mass and high asthenia degree was found, configuring a condition of sarcopenia in about one third of patients with IBD. (4) Conclusions: Sarcopenia is common in IBD patients and it is associated with fatigue perception as well as a reduction in quality of life. Therefore, routine assessment of nutritional status and body composition should be a cornerstone in clinical practice, bringing gastroenterologists and nutritionists closer together for a compact, defined picture.

29 August 2024 in BMJ Open Gastroenterology
Verified
Journal Article
Open access
PDF file
DNDaniele Napolitano
Daniele Napolitano
EVErcole Vellone
Ercole Vellone
PIPaolo Iovino
Paolo Iovino
FSFranco Scaldaferri
Franco Scaldaferri
ACAntonello Cocchieri
Antonello Cocchieri
Introduction Supporting patient self-care and the contribution of their caregivers is crucial in chronic illness care. Inflammatory bowel disease (IBD) is a chronic condition whose prevalence is expected to double, especially in Western countries. IBD symptoms can negatively impact patients’ well-being, causing high anxiety, depression, stress and reduced quality of life. These symptoms also affect the health of family members and friends, who often take on caregiving roles during exacerbations. Knowledge about self-care in IBD (IBD-SELF) is limited, and few studies have explored this context. This paper outlines a research protocol for a multicentre longitudinal study to investigate patient self-care and caregiver contributions to IBD-SELF. Methods and analysis A sample of 250 consecutive patients diagnosed with IBD and their caregivers will be recruited from 9 dedicated IBD units in northern, central and southern Italy during outpatient visits. Data collection will occur at baseline, 6 and 12 months after enrolment. Multivariable regressions, path analyses and structural equation models will identify predictors (eg, health literacy, caregiver burden and depression) and outcomes (use of healthcare services, disease severity and quality of life) of self-care and caregiver contributions. Dyadic analyses will control for the interdependence of dyad members. Ethics and dissemination Ethical approval was obtained from the Territorial Ethics Committee (Lazio 3) N. 0023486/23 and registered on ClinicalTrials.gov (Identifier number: NCT06015789). This study will enhance our understanding of the self-care process in the patient–caregiver dyad in IBD, aiding the design of future educational interventions and promoting greater patient and caregiver involvement in the care pathway. Trial registration number ClinicalTrials.gov: NCT06015789.

20 January 2024 in Indian Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
DNDaniele Napolitano
Daniele Napolitano
CSCarlo Romano Settanni
Carlo Romano Settanni
LPLaura Parisio
Laura Parisio
NONicoletta Orgiana
Nicoletta Orgiana
APAndrea Poscia
Andrea Poscia
FSFranco Scaldaferri
Franco Scaldaferri

7 April 2025 in Digestive and Liver Disease
Verified
Journal Article
Closed access
GFGionata Fiorino
Gionata Fiorino
FCFlavio Andrea Caprioli
Flavio Andrea Caprioli
SOSara Onali
Sara Onali
Fabio Salvatore MacalusoFabio Salvatore Macaluso
Fabio Salvatore Macaluso
CBCristina Bezzio
Cristina Bezzio
MFMassimo Claudio Fantini
Massimo Claudio Fantini

24 October 2025
Verified
Open access
DNDaniele Napolitano
Daniele Napolitano
SCSilvia Cilluffo
Silvia Cilluffo
VAValeria Amatucci
Valeria Amatucci
Davide BartoliDavide Bartoli
Davide Bartoli
VBValentina Biagioli
Valentina Biagioli
EVErcole Vellone
Ercole Vellone
Inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), requires complex self-care behaviors to manage symptoms and maintain quality of life. Despite its importance, self-care in IBD remains poorly understood. This study aims to investigate self-care practices and the sociodemographic and clinical determinants of self-care among patients with IBD. A multicenter cross-sectional study was conducted in nine IBD units in Italy. Patients were enrolled between April and June 2024. Self-care was assessed using the Self-Care of Chronic Illness Inventory, covering self-care maintenance, self-care monitoring, and self-care management. Socio-demographic and clinical data were collected through structured questionnaires. Multiple linear regressions examined the relationships between patient characteristics and self-care dimensions. The N-ECCO Research Grant supported the study. Among 452 patients (49.3% CD, 50.7% UC), mean self-care scores were 72.84 ± 12.57 (self-care maintenance), 81.14 ± 17.94 (self-care monitoring), and 67.73 ± 16.99 (self-care management). Ulcerative colitis patients demonstrated significantly better self-care management than CD patients (P = .002). Higher disease activity was associated with worse self-care maintenance (β = –.11, P = .030), while supplement use predicted better self-care maintenance (β = .10, P = .028). For self-care monitoring, female gender (β = .11, P = .020) and supplement use (β = .13, P = .005) were positively associated with higher scores. Inflammatory bowel disease patients demonstrated adequate self-care maintenance and monitoring, but their self-care management was suboptimal. Female gender and supplement use were associated with better self-care monitoring; disease activity worsened self-care maintenance. Ulcerative colitis patients had better self-care management than CD, highlighting the need for tailored interventions to improve self-care.